calendar
24,466 catalysts · 16,606 approval · 3,309 device 510k · 2,293 grant · 842 device pma · 771 device recall · 645 recall
next 91 dayslessmore
MonWedFri
24,466 catalysts · 16,606 approval · 3,309 device 510k · 2,293 grant · 842 device pma · 771 device recall · 645 recall
Sponsor: SANOFI AVENTIS US. Form: INJECTABLE. Route: INJECTION
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
Sponsor: SANOFI AVENTIS US. Form: CAPSULE. Route: ORAL
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION
Sponsor: EXELIXIS. Form: CAPSULE. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION
Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PRODS. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PRODS. Form: TABLET. Route: ORAL
Sponsor: LABS JUVISE. Form: CAPSULE. Route: ORAL
Sponsor: VALEANT LUXEMBOURG. Form: INJECTABLE. Route: INJECTION
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION
Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL
Sponsor: PAI HOLDINGS. Form: SOLUTION. Route: ORAL
Sponsor: GENUS LIFESCIENCES. Form: SOLUTION. Route: ORAL
Sponsor: ACTAVIS MID ATLANTIC. Form: SOLUTION. Route: ORAL
Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL
Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL
Sponsor: ACTAVIS ELIZABETH. Form: TABLET. Route: SUBLINGUAL
Sponsor: SUN PHARM. Form: TABLET. Route: SUBLINGUAL
Sponsor: TEVA PHARMS USA. Form: TABLET. Route: SUBLINGUAL
Sponsor: ETHYPHARM. Form: TABLET. Route: SUBLINGUAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: SUN PHARM. Form: TABLET. Route: SUBLINGUAL
Sponsor: PHARMOBEDIENT. Form: TABLET. Route: SUBLINGUAL
Sponsor: PHARMOBEDIENT. Form: TABLET. Route: SUBLINGUAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: SUBLINGUAL
Sponsor: ACTAVIS ELIZABETH. Form: TABLET. Route: SUBLINGUAL
Sponsor: ACTAVIS ELIZABETH. Form: TABLET. Route: SUBLINGUAL
Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL
Sponsor: RUBICON RESEARCH. Form: TABLET. Route: SUBLINGUAL
Sponsor: ACTAVIS ELIZABETH. Form: TABLET. Route: SUBLINGUAL
Sponsor: SUN PHARM. Form: TABLET. Route: SUBLINGUAL
Sponsor: TEVA PHARMS USA. Form: TABLET. Route: SUBLINGUAL
Sponsor: TEVA PHARMS USA. Form: TABLET. Route: SUBLINGUAL
Sponsor: ETHYPHARM. Form: TABLET. Route: SUBLINGUAL
Sponsor: REACX PHARMS. Form: IMPLANT. Route: IMPLANTATION
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: SUN PHARM. Form: TABLET. Route: SUBLINGUAL
Sponsor: HIKMA. Form: TABLET. Route: SUBLINGUAL
Sponsor: HIKMA. Form: TABLET. Route: SUBLINGUAL
Sponsor: PHARMOBEDIENT. Form: TABLET. Route: SUBLINGUAL
Sponsor: ETHYPHARM. Form: TABLET. Route: SUBLINGUAL